Escolar Documentos
Profissional Documentos
Cultura Documentos
Abstract
Transplantation of bone marrow derived mesenchymal stromal cells (MSC) or olfactory ensheathing cells (OEC) have
demonstrated beneficial effects after spinal cord injury (SCI), providing tissue protection and improving the functional
recovery. However, the changes induced by these cells after their transplantation into the injured spinal cord remain largely
unknown. We analyzed the changes in the spinal cord transcriptome after a contusion injury and MSC or OEC
transplantation. The cells were injected immediately or 7 days after the injury. The mRNA of the spinal cord injured segment
was extracted and analyzed by microarray at 2 and 7 days after cell grafting. The gene profiles were analyzed by clustering
and functional enrichment analysis based on the Gene Ontology database. We found that both MSC and OEC transplanted
acutely after injury induce an early up-regulation of genes related to tissue protection and regeneration. In contrast, cells
transplanted at 7 days after injury down-regulate genes related to tissue regeneration. The most important change after
MSC or OEC transplant was a marked increase in expression of genes associated with foreign body response and adaptive
immune response. These data suggest a regulatory effect of MSC and OEC transplantation after SCI regarding tissue repair
processes, but a fast rejection response to the grafted cells. Our results provide an initial step to determine the mechanisms
of action and to optimize cell therapy for SCI.
Citation: Torres-Espn A, Hernandez J, Navarro X (2013) Gene Expression Changes in the Injured Spinal Cord Following Transplantation of Mesenchymal Stem
Cells or Olfactory Ensheathing Cells. PLoS ONE 8(10): e76141. doi:10.1371/journal.pone.0076141
Editor: Hatem E. Sabaawy, UMDNJ-Robert wood Johnson Medical School, United States of America
Received May 22, 2013; Accepted August 20, 2013; Published October 11, 2013
Copyright: 2013 Torres-Espn et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Ministerio de Ciencia e Innovacion (grant SAF2009-12495), and funds from CIBERNED and Red de Terapia
Celular (TERCEL), Instituto de Salud Carlos III of Spain, and FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: xavier.navarro@uab.cat
Introduction
Spinal cord injury (SCI) leads to partial or complete loss of
motor, sensory and autonomic functions and secondary impairments below the injury level, due to damage to the local circuitry
of the spinal cord and the interruption of ascending and
descending neural pathways. SCI results in a sequence of
coordinated changes in gene and protein expression profile
associated with physiopathological events, including hemorrhage,
inflammatory and immune activation, excitotoxicity, oxidative
stress, and neuronal activity imbalances [1,2,3,4,5].
Cell therapy has become a promising approach for repairing the
injured spinal cord [6,7,8,9,10]. Several pre-clinical studies have
demonstrated that transplantation of mesenchymal stromal cells
(MSC) [11,12,13,14,15] or olfactory ensheathing cells (OEC)
[16,17,18,19,20,21] reduces tissue damage and improves functional outcomes in different models of SCI, although other studies
failed to replicate such beneficial results [22,23,24,25,26]. Little is
known about the mechanisms underlying the potential benefits
after cell grafting into the injured spinal cord. Regarding the MSC
it has been suggested that the effects are due to their capability to
secrete and/or induce the expression of protective molecules such
as BDNF and GDNF [12,15], to modulate inflammation [27,28]
and to generate a more permissive environment for axonal
PLOS ONE | www.plosone.org
associated with the immune response were also found upregulated, indicative of cell rejection.
Cell Labeling
For identification after grafting, both cell types were transfected
with a lentiviral vector encoding for green fluorescent protein
(GFP) under EF1a promoter. MSC in passage 2 were plated at
2000 cells/cm2 and incubated with lentiviruses at MOI of 10
during 48 h. Then, the medium was changed and the cells
cultured as described above. OEC transduction was done at 23
days of selection using the same lentiviruses at MOI of 50 for 24
hours. Then, the medium was replaced by complete culture
medium and the cells cultured for 5 more days. Around 96% of
transfection efficacy was determined by GFP+ cell counting for
both MSC and OEC.
Sample Preparation
The rats for the transcriptome study in each experimental group
were sacrificed randomly at 2 (n = 4) or 7 (n = 4) days post cell
injection (dpi). The groups were identified according to the code
transplant day.day_of sacrifice_post-treatment. For example, the group of
animals transplanted with MSC at 7 days post-lesion and
sacrificed 2 days after treatment was labeled as MSC 7.2. Animals
were decapitated after deep anesthesia, and a spinal cord segment
(5 mm long) centered in the contusion epicenter was harvested
and maintained in RNA-later solution (Qiagen, Barcelona, Spain).
A spinal cord segment of intact animals (n = 4) was also obtained at
the same vertebral level as for the injured animals. The samples
2
Microarray Validation
To validate the results obtained by microarray analysis, in silico
comparison of the SCI differential expressed genes lists and RTPCR of target genes were performed.
In silico validation. Three different data profiles were
selected in the GEO database: GSE464 (spinal cord injury
contusion and regeneration time course in rats: above T9 (RGU34A)), GSE5296 (spinal cord injury contusion model in mice:
time course), and GSE22161 (comparative gene expression
analysis of thoracic spinal cord from G93A SOD1 mutant rats
and from wild type littermates following mild compression injury).
For the comparison of the GEO profile with our results, upregulated and down-regulated lists of genes were obtained from
the GEO data analysis tools, filtered with our microarray profile to
eliminate the probes not assessed in our chip, and compared with
the corresponding up-regulated and down-regulated lists that we
obtained from our samples. The percentages of concordant and
discordant genes with respect to the total changed genes in the
GEO data up-regulated and down-regulated profiles were
calculated. Thus, if one gene appeared up-regulated at the same
time in the GSE464 and in our results this gene contributed to the
percentage of concordance. Genes that were not coincident in the
compared list contributed to the percentage of discordance, in
which we distinguished the genes that changed in the GEO profile
but not in our data and the genes that changed in opposite
direction than in our results.
RT-PCR. 1 mg RNA of each sample was reverse-transcribed
using 10 mmol/L DTT, 200 U M-MuLV reverse transcriptase
(New England BioLabs, Barcelona, Spain), 10 U RNase Out
Ribonuclease Inhibitor (Invitrogen), 1 mmol/L oligo(dT) and
1 mmol/L of random hexamers (BioLabs, Beverly, MA, USA).
The reverse transcription cycle conditions were 25uC for 10 min,
42uC for 1 h and 72uC for 10 min. We analyzed the mRNA
expression by means of specific primer sets (Table S1). Glyceraldehyde 3-phosphate dehydrogenase (GADPH) expression was
used to normalize the expression levels of the different genes of
interest. Gene-specific mRNA analysis was performed by SYBRgreen PCR using the MyiQ5 PCR detection system (Bio-Rad
Laboratories, Barcelona, Spain). We previously fixed the optimal
concentration of the cDNA to be used as template for each gene
analysis to obtain reliable CT (threshold cycle) values for
quantification. Four samples were used per condition and each
one was run in duplicate. The thermal cycling conditions
comprised 3 min polymerase activation at 95uC, 40 cycles of
10 s at 95uC for denaturation and 30 s at 62uC for annealing and
extension, followed by a DNA melting curve for determination of
amplification specificity. CT values were obtained and analyzed
using BioRad Software. Fold change in gene expression was
estimated using the CT comparative method (22DDCT) normalizing to GADPH CT values and relative between pairs of samples.
Immunohistochemistry
Spinal cord sections of GFP+ cells transplanted rats were
processed for immunohistochemistry against GFP. Tissue sections
were blocked with TBS-0.3% Triton-5% fetal bovine serum and
incubated for 24 h at 4uC with the antibody rabbit anti-GFP (1/
200, Life Technologies). After washes, sections were incubated for
2 h at room temperature with secondary antibody donkey antirabbit AlexaFluor 488 (1/200, Jackson Immunoresearch). Slides
were dehydrated and mounted with Citoseal 60 (Thermo Fisher
Scientific, Madrid, Spain). Images were obtained with a digital
camera (Olympus DP50) attached to the microscope (Olympus
BX51). Analysis of the area occupied by GFP+ cells was performed
using 8 spinal cord sections (separated by 360 mm between pairs)
of each animal. Images of the spinal cord injured segment were
taken at 40x with the same setting and the total section was
mounted using Photoshop software (Adobe Systems Inc.). The
microphotographs were analyzed using ImageJ software. The GFP
labeled area in each section was measured after defining a
threshold for background correction. The volume of the graft,
spared tissue, cavity and total spinal cord injured segment were
calculated using the Cavalieris estimator of morphometric
volume. The statistical analysis was performed using one-way
ANOVA.
Microarray
The microarray hybridization and the statistical processing of
raw data were performed by a specialized service (Scientific and
Technical Support Unit and Statistics and Bioinformatics Unit,
Vall dHebron Research Institute, Barcelona, Spain). For the gene
expression an Affymetrix RAT Exon/Gene 1.1 ST chip array was
used according to the manufacturer protocol, analyzing each
animal individually as biological replicates of four animals per
experimental condition. The array data are available in Gene
Expression Omnibus database (GEO, National Centre of
Biotechnology Information), accession number GSE46988.
Data analysis. The images of hybridized microarrays were
processed with the Expression Console software (Affymetrix). Raw
expression values obtained directly from.CEL files were preprocessed using the RMA method [39], a three-step process that
integrates background correction, normalization and filtering of
probes values. Data were first submitted to non-specific filtering to
remove low signal genes (those genes whose mean signal in each
group did not exceed a minimum threshold) and low variability
genes (those genes whose standard deviation between all samples
did not exceed a minimum threshold). The selection of differentially expressed genes between conditions was based on a linear
model analysis with empirical Bayes moderation of the variance
estimated following the methodology developed by Smyth [40]
PLOS ONE | www.plosone.org
Cluster Analyses
Hierarchical cluster analyses were performed using the algorithms for complete linkage and correlation (uncentered) similarity
metrics in the software Cluster 3.0 and visualized using TreeView,
both developed by Eisen et al. (1998) [41]. To determine the
similarity of the experimental conditions, an array hierarchical
clustering of the transplanted groups (MSC 0.2, MSC 0.7, MSC
7.2, MSC 7.7, OEC 0.2, OEC 0.7, OEC 7.2, OEC 7.7) was
performed. To compare the differentially expressed profiles
between MSC (MSC vs. VHC) and OEC (OEC vs. VHC), a
gene hierarchical clustering was performed for each experimental
condition. In this analysis a specific list of genes were selected from
the resulted clusters using the criteria: genes exclusively up- or
down-regulated in MSC or OEC transplanted animals and genes
that were up- or down-regulated in both cell injected group.
Results
Data Presentation
Microarray Validation
Microarray data were validated by both in silico and RT-PCR
quantitative analyses. For the in silico comparison, the transcriptional profile of the SCI samples was contrasted with three
microarrays data published in the GEO database: GSE464,
GSE5296 and GSE22161. After filtering genes that were
differentially expressed, we found that the genes that were upPLOS ONE | www.plosone.org
Figure 1. Grafted cell survival in the injured spinal cord. GFP labeled MSC and OEC were transplanted into the spinal cord after contusion at
acute or delayed time. At 7 days post injection (dpi), both OEC (A) and MSC (B) were localized in the spinal cord parenchyma (delimited by dotted
lines), surrounding the injection points (arrows). The volume quantification of the GFP signal showed no significant differences between groups (C).
Scale bar = 2000 mm.
doi:10.1371/journal.pone.0076141.g001
Figure 2. Changes in gene expression after acute MSC and OEC transplantation. The figure shows the gene profiles comparison between
MSC and OEC at 2 (A) and 7 (B) days after acute transplantation in rats with a spinal cord contusion. Each panel contains the Venn diagram (top left)
showing the number of differentially expressed genes (in red, up-regulated genes; in green, down-regulated genes), the heat map of the
corresponding hierarchical clustering with the clusters trees, and the summary tables of the functional annotation analysis results. In the heat map
the columns represent the mean of four animals analyzed per group.
doi:10.1371/journal.pone.0076141.g002
Figure 3. Changes in gene expression after delayed MSC and OEC transplantation. The figure shows the gene profiles comparison
between MSC and OEC at 2 (A) and 7 (B) days after one week delayed transplantation in rats with a spinal cord contusion. Each panel contains the
Venn diagram (top left) showing the number of differentially expressed genes (in red, up-regulated genes; in green, down-regulated genes), the heat
map of the corresponding hierarchical clustering with the clusters trees, and the summary tables of the functional annotation analysis results. In the
heat map the columns represent the mean of four animals analyzed per group.
doi:10.1371/journal.pone.0076141.g003
Discussion
Several studies have shown that transplantation of MSC and of
OEC after SCI exert beneficial effects on functional recovery,
tissue protection, axonal regeneration and remyelination. However, the mechanisms and changes triggered by the grafted cells on
the spinal cord are still poorly understood. The results of the
present study contribute to the knowledge of the role played by
MSC and OEC transplants in the injured spinal cord, and provide
important information regarding the genes and pathways modified
by these cells when grafted into the injured spinal cord.
Figure 5. ECM related genes. Graphical representation of genes related to ECM remodeling, such as matrix metalloproteases (A), collagen
associated genes (B) and other genes related to collagen interaction proteins (C). Each graph shows the fold changes of the corresponding gene after
acute (2 and 7 days post injury) and delayed (9 and 14 days post injury) cell transplantation in comparison to vehicle values. Data are represented as
mean 6 SEM. $ p,0.05 OEC vs. vehicle, & p,0.05 MSC vs. vehicle.
doi:10.1371/journal.pone.0076141.g005
Figure 6. Rejection response related genes. Graphical representation of some genes related to immune response, such as lymphocyte markers
(A), cytokines (B), major histocompatibility complex I and II (C) and C3, the complement component 3 (D). Each graph shows the fold changes of the
corresponding gene after acute (2 and 7 days post injury) and delayed (9 and 14 days post injury) cell transplantation in comparison to vehicle value.
Data are represented as mean 6 SEM. $ p,0.05 OEC vs. vehicle, & p,0.05 MSC vs. vehicle.
doi:10.1371/journal.pone.0076141.g006
Figure 7. Specific genes modulated by cells. Graphical representation of some genes that were specifically expressed by acute MSC (A), acute
OEC (B), delayed MSC (C) or delayed OEC (D) transplantations. Each graph shows the fold changes of the corresponding gene after acute (2 and 7
days post injury) and delayed (9 and 14 days post injury) cell transplantation in comparison to vehicle value. Data are represented as mean 6 SEM. $
p,0.05 OEC vs. vehicle, & p,0.05 MSC vs. vehicle.
doi:10.1371/journal.pone.0076141.g007
10
Conclusion
Our data provide an overview of the mechanisms modulated by
MSC and OEC when transplanted after SCI. The changes
observed in gene expression profile suggest that transplantation of
both, MSC and OEC, accelerates and/or enhances tissue repair
events during the early stages of the injury, while it tends to resolve
these processes at later time points. However, the activation of the
adaptive immune response in the grafted spinal cord after
transplantation is indicative of cell rejection. Further investigations
are needed to better understand the neuroprotective actions of
MSC and OEC grafts, as well as to avoid cell rejection to optimize
cell therapies for clinical application in SCI.
Figure S1 Microarray data validation. (A) In silico comparison of our gene array results showed a high concordance of upregulated genes and down-regulated genes with results previously
published after the same type of injury in rats (GSE464) and in
mice (GSE5296), but not with another type of SCI in rats
(GSE22161). (B) The validation of some target genes by RT-PCR
indicated good concordance between expression changes obtained
by microarray and by RT-PCR (Pearson correlation, r = 0.87,
p,0.0001). In this comparison a few discrepancies were observed
but only in target genes that did not reach the cut-off of significant
changes (inside the square in B).
(TIF)
Figure S2 Rejection response related genes. Graphical
acute (2 and 7 days post injury) and delayed (9 and 14 days post
injury) cell transplantation in comparison to vehicle value. Data
are represented as mean 6 SEM. $ p,0.05 OEC vs. vehicle, &
p,0.05 MSC vs. vehicle.
(TIF)
Table S12
(DOC)
Table S13
DOWN.
(DOC)
(DOC)
(DOC)
Table S16
(DOC)
(DOC)
Table S17
7.7 UP.
(DOC)
DOWN.
(DOC)
Table S4
0.2 UP.
(DOC)
Table S18
(DOC)
Table S6 Functional annotation cluster: MSC 0.7 UP.
Table S19
(DOC)
DOWN.
(DOC)
(DOC)
Table S8
0.7 UP.
(DOC)
Acknowledgments
DOWN.
(DOC)
We thank Monica Espejo, Jessica Jaramillo and Marta Morell for technical
help.
Author Contributions
Table S11
(DOC)
References
11. Chopp M, Xue CA, Zhang H, Li Y, Wang L, et al. (2000) Spinal cord injury in
rat?: treatment with bone marrow stromal cell transplantation. NeuroReport 11:
30013005.
12. Himes BT, Neuhuber B, Coleman C, Kushner R, Swanger SA, et al. (2006)
Recovery of function following grafting of human bone marrow-derived stromal
cells into the injured spinal cord. Neurorehabil. Neural Repair. 20: 278296.
13. Hofstetter CP, Schwarz EJ, Hess D, Widenfalk J, El Manira A, et al. (2002)
Marrow stromal cells form guiding strands in the injured spinal cord and
promote recovery. PNAS 99: 21992204.
14. Neuhuber B, Himes BT, Shumsky JS, Gallo G, Fischer I (2005) Axon growth
and recovery of function supported by human bone marrow stromal cells in the
injured spinal cord exhibit donor variations. Brain Res. 1035: 7385.
15. Quertainmont R, Cantinieaux D, Botman O, Sid S, Schoenen J, et al. (2012)
Mesenchymal stem cell graft improves recovery after spinal cord injury in adult
rats through neurotrophic and pro-angiogenic actions. PloS One 7: e39500.
16. Garca-Alas G, Lopez-Vales R, Fores J, Navarro X, Verdu E (2004) Acute
transplantation of olfactory ensheathing cells or Schwann cells promotes
recovery after spinal cord injury in the rat. J. Neurosci. Res. 75: 632641.
17. Li Y, Field PM, Raisman G (1998) Regeneration of adult rat corticospinal axons
induced by transplanted olfactory ensheathing cells. J. Neurosci. 18: 10514
10524.
18. Lopez-Vales R, Fores J, Verdu E, Navarro X (2006) Acute and delayed
transplantation of olfactory ensheathing cells promote partial recovery after
complete transection of the spinal cord. Neurobiol. Dis. 21: 5768.
19. Lu J, Feron F, Mackay-Sim A, Waite PM (2002) Olfactory ensheathing cells
promote locomotor recovery after delayed transplantation into transected spinal
cord. Brain 125: 1421.
1. Aimone JB, Leasure JL, Perreau VM, Thallmair M (2004) Spatial and temporal
gene expression profiling of the contused rat spinal cord. Exp. Neurol. 189: 204
221.
2. Afjehi-Sadat L, Brejnikow M, Kang SU, Vishwanath V, Walder N, et al. (2010)
Differential protein levels and post-translational modifications in spinal cord
injury of the rat. J. Prot. Res. 9: 15911597.
3. Carmel JB, Galante A, Soteropoulos P, Tolias P, Recce M, et al. (2001) Gene
expression profiling of acute spinal cord injury reveals spreading inflammatory
signals and neuron loss. Physiol. Genomics 7: 201213.
4. De Biase A, Knoblach SM, Di Giovanni S, Fan C, Molon A, et al. (2005) Gene
expression profiling of experimental traumatic spinal cord injury as a function of
distance from impact site and injury severity. Physiol. Genomics 22: 368381.
5. Di Giovanni S, Knoblach SM, Brandoli C, Aden SA, Hoffman EP, et al. (2003)
Gene profiling in spinal cord injury shows role of cell cycle in neuronal death.
Ann. Neurol. 53: 454468.
6. Coutts M, Keirstead HS (2008) Stem cells for the treatment of spinal cord injury.
Exp. Neurol. 209: 368377.
7. Hernandez J, Torres-Espn A, Navarro X (2011) Adult stem cell transplants for
spinal cord injury repair: current state in preclinical research. Curr. Stem Cell
Res. Ther. 6: 273287.
8. Mothe AJ, Tator CH (2012) Advances in stem cell therapy for spinal cord injury.
Sci. Med. 122: 38243834.
9. Sahni V, Kessler JA (2010) Stem cell therapies for spinal cord injury. Nat. Rev.
Neurol. 6: 363372.
10. Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, Hill CE, Sparling JS, et al. (2011)
A systematic review of cellular transplantation therapies for spinal cord injury. J.
Neurotrauma 28: 16111682.
12
46. Caplan AI, Correa D (2011) The MSC: an injury drugstore. Cell Stem Cell 9:
1115.
47. Valtieri M, Sorrentino A (2008) The mesenchymal stromal cell contribution to
homeostasis. J. Cell Physiol. 217: 296300.
48. Van der Slot AJ, Zuurmond A-M, Bardoel AFJ, Wijmenga C, Pruijs HEH, et al.
(2003) Identification of PLOD2 as telopeptide lysyl hydroxylase, an important
enzyme in fibrosis. J. Biol. Chem. 278: 4096740972.
49. Okada M, Miyamoto O, Shibuya S, Zhang X, Yamamoto T, et al. (2007)
Expression and role of type I collagen in a rat spinal cord contusion injury
model. Neurosci. Res. 58: 371377.
50. Cherepanova OA, Pidkovka NA, Sarmento OF, Yoshida T, Adiguzel E, et al.
(2010) Oxidized phospholipids induce type VIII collagen expression and
vascular smooth muscle cell migration. Circul. Res. 104: 609618.
51. Gilkes DM, Bajpai S, Chaturvedi P, Wirtz D, Semenza GL (2013) Hypoxiainducible factor 1 (HIF-1) promotes extracellular matrix remodeling under
hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in
fibroblasts. J. Biol. Chem. 288: 1081910829.
52. Kosaki N, Takaishi H, Kamekura S, Kimura T, Okada Y, et al. (2007) Impaired
bone fracture healing in matrix metalloproteinase-13 deficient mice. Biochem.
Biophys. Res. Commun. 354: 846851.
53. Kudo Y, Iizuka S, Yoshida M, Tsunematsu T, Kondo T, et al. (2012) Matrix
metalloproteinase-13 (MMP-13) directly and indirectly promotes tumor
angiogenesis. J. Biol. Chem. 287: 3871638728.
54. Toriseva M, Laato M, Carpen O, Ruohonen ST, Savontaus E, et al. (2012)
MMP-13 regulates growth of wound granulation tissue and modulates gene
expression signatures involved in inflammation, proteolysis, and cell viability.
PloS One 7: e42596.
55. Lu D-Y, Yu W-H, Yeh W-L, Tang C-H, Leung Y-M, et al. (2009) Hypoxiainduced matrix metalloproteinase-13 expression in astrocytes enhances permeability of brain endothelial cells. J. Cell. Physiol. 220: 163173.
56. Siefert S, Sarkar R (2012) Matrix metalloproteinases in vascular physiology and
disease. Vascular 20: 210216.
57. Kudo A (2011) Periostin in fibrillogenesis for tissue regeneration. Cell. Mol. Life
Sci. 68: 32013207.
58. Bieback K, Wuchter P, Besser D, Franke W, Becker M, et al. (2012)
Mesenchymal stromal cells (MSCs): science and f(r)iction. J. Molecular Med.
90: 773782.
59. Jackson WM, Nesti LJ, Tuan RS (2012) Concise review: clinical translation of
wound healing therapies based on mesenchymal stem cells. Stem Cell Trans.
Med. 1: 4450.
60. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, et al. (2009)
Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent
reprogramming of host macrophages to increase their interleukin-10 production.
Nat. Med. 15: 4249.
61. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, et al. (2008) Mesenchymal stem cellmediated immunosuppression occurs via concerted action of chemokines and
nitric oxide. Cell Stem Cell 2: 141150.
62. Jeon YK, Jang YH, Yoo DR, Kim SN, Lee SK, et al. (2010) Mesenchymal stem
cells interaction with skin: Wound-healing effect on fibroblast cells and skin
tissue. Wound Repair Regen. 18: 655661.
63. Peranteau WH, Zhang L, Muvarak N, Badillo AT, Radu A, et al. (2008) IL-10
overexpression decreases inflammatory mediators and promotes regenerative
healing in an adult model of scar formation. J. Invest. Dermatol. 128: 1852
1860.
64. Chen L, Tredget EE, Wu PY, Wu Y (2008) Paracrine factors of mesenchymal
stem cells recruit macrophages and endothelial lineage cells and enhance wound
healing. PLoS One 3: e1886.
65. Kim CH, Lee JH, Won JH, Cho MK (2011) Mesenchymal stem cells improve
wound healing in vivo via early activation of matrix metalloproteinase-9 and
vascular endothelial growth factor. J. Korean Med. Sci. 26: 726733.
66. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, et al. (2004) Local
delivery of marrow-derived stromal cells augments collateral perfusion through
paracrine mechanisms. Circulation 109: 15431549.
67. Park KS, Kim YS, Kim JH, Choi B, Kim SH, et al. (2010) Trophic molecules
derived from human mesenchymal stem cells enhance survival, function, and
angiogenesis of isolated islets after transplantation. Transplantation 89: 509517.
68. Gruber R, Kandler B, Holzmann P, Vogele-Kadletz M, Losert U, et al. (2005)
Bone marrow stromal cells can provide a local environment that favors
migration and formation of tubular structures of endothelial cells. Tissue Eng.
11: 896903.
69. Kaigler D, Krebsbach PH, Polverini PJ, Mooney DJ (2003) Role of vascular
endothelial growth factor in bone marrow stromal cell modulation of endothelial
cells. Tissue Eng. 9: 95103.
70. Lozito TP, Taboas JM, Kuo CK, Tuan RS (2009) Mesenchymal stem cell
modification of endothelial matrix regulates their vascular differentiation. J. Cell
Biochem. 107: 706713.
71. Goritz C, Dias DO, Tomilin N, Barbacid M, Shupliakov O, et al. (2011) A
pericyte origin of spinal cord scar tissue. Science 333: 238242.
72. Keating A (2012) Mesenchymal stromal cells: new directions. Cell Stem Cell 10:
709716.
73. Wang S, Qu X, Zhao RC (2012) Clinical applications of mesenchymal stem
cells. J. Hematol. Oncol. 5: 19.
13
74. Kwak EK, Kim JW, Kang KS, Lee YH, Hua QH, et al. (2005) The role of
inducible nitric oxide synthase following spinal cord injury in rat. J. Kor. Med.
Sci. 20: 663669.
75. Lopez-Vales R, Garca-Alas G, Guzman-Lenis MS, Fores J, Casas C, et al.
(2006) Effects of COX-2 and iNOS inhibitors alone or in combination with
olfactory ensheathing cell grafts after spinal cord injury. Spine 31: 11001106.
76. Lu P, Yang H, Culbertson M, Graham L, Roskams AJ, et al. (2006) Olfactory
ensheathing cells do not exhibit unique migratory or axonal growth-promoting
properties after spinal cord injury. J. Neurosci. 26: 1112011130.
77. Ruitenberg M, Plant G, Christensen C, Blits B, Niclou S, et al. (2002) Viral
vector-mediated gene expression in olfactory ensheathing glia implants in the
lesioned rat spinal cord. Gene Therapy 9: 135146.
78. Dressel R, Walter L, Gunther E (2001) Genomic and funtional aspects of the rat
MHC, the RT1 complex. Immunol. Rev. 184: 8295.
79. Gunther E, Walter L (2001) The major histocompatibility complex of the rat
(Rattus norvegicus). Immunogenicity 53: 520542.
80. Cole DK, Laugel B, Clement M, Price DA, Wooldridge L, et al. (2012) The
molecular determinants of CD8 co-receptor function. Immunology 137: 139
148.
81. Heath WR and Carbone FR (2001) Cross-presentation, dendritic cells, tolerance
and immunity. Annu. Rev. Immunol. 19: 4764.
82. Holling TM, Schooten E, Van Den Elsen PJ (2004) Function and regulation of
MHC class II molecules in T-lymphocytes: of mice and men. Human Immunol.
65: 282290.
83. Muller M, Carter S, Hofer MJ, Campbell IL (2010) Review: The chemokine
receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in
neuroimmunitya tale of conflict and conundrum. Neuropathol. Appl.
Neurobiol. 36: 368387.
84. Oo YH, Shetty S, Adams DH (2010) The role of chemokines in the recruitment
of lymphocytes to the liver. Digest. Dis. 28: 3144.
85. Rot A, Von Andrian UH (2004) Chemokines in innate and adaptive host
defense: basic chemokinese grammar for immune cells. Ann. Rev. Immunol. 22:
891928.
86. Swanger S, Neuhuber B, Himes B, Bakshi A, Fischer I (2005) Analysis of
allogeneic and syngeneic bone marrow stromal cell graft survival in the spinal
cord. Cell Transplant. 10: 775786.
87. Ronsyn MW, Daans J, Spaepen G, Chatterjee S, Vermeulen K, et al. (2007)
Plasmid-based genetic modification of human bone marrow-derived stromal
cells?: analysis of cell survival and transgene expression after transplantation in
rat spinal cord. BMC Biotech. 17: 117.
88. Nandoe Tewarie RDS, Hurtado A, Ritfeld GJ, Rahiem ST, Wendell DF, et al.
(2009) Bone marrow stromal cells elicit tissue sparing after acute but not delayed
transplantation into the contused adult rat thoracic spinal cord. J. Neurotrauma
26: 23132322.
89. Jung DI, Ha J, Kang BT, Kim JW, Quan FS, et al. (2009) A comparison of
autologous and allogenic bone marrow-derived mesenchymal stem cell
transplantation in canine spinal cord injury. J. Neurol. Sci. 285: 6777.
14